Filing Flows › SeaStar Medical Holding (ICU) › Recalls, complaints & regulation
SeaStar Medical Holding (ICU): clinical trials
SeaStar Medical Holding (ICU) beyond its filings: 3 active clinical trials.
SeaStar Medical Holding's latest quarter
SeaStar Medical Holding, Q2 2026: revenue $615K (+82% year over year), operating margin -616.4%, net loss $3.7M, operating cash flow −$3.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does SeaStar Medical Holding have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.